All-In with Chamath, Jason, Sacks & Friedberg cover image

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

All-In with Chamath, Jason, Sacks & Friedberg

00:00

Retatrutide Hype Reaches Peak Levels

Chamath Palihapitiya asks about retatrutide, and David Friedberg summarizes striking trial results on weight loss, blood markers, liver fat, and possible anti-inflammatory benefits.

Play episode from 58:42
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app